387 related articles for article (PubMed ID: 16650133)
1. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
[TBL] [Abstract][Full Text] [Related]
2. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
[TBL] [Abstract][Full Text] [Related]
3. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
4. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
Brandt C; Bethmann K; Gastens AM; Löscher W
Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
[TBL] [Abstract][Full Text] [Related]
5. Development of tolerance to levetiracetam in rats with chronic epilepsy.
van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
[TBL] [Abstract][Full Text] [Related]
6. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
[TBL] [Abstract][Full Text] [Related]
7. Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain.
Wen T; Liu YC; Yang HW; Liu HY; Liu XD; Wang GJ; Xie L
J Neurol Sci; 2008 Jul; 270(1-2):99-106. PubMed ID: 18440557
[TBL] [Abstract][Full Text] [Related]
8. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
Bankstahl JP; Löscher W
Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
[TBL] [Abstract][Full Text] [Related]
9. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.
Brandt C; Volk HA; Löscher W
Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
11. Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy.
Holtman L; van Vliet EA; Edelbroek PM; Aronica E; Gorter JA
Epilepsy Res; 2010 Sep; 91(1):49-56. PubMed ID: 20643531
[TBL] [Abstract][Full Text] [Related]
12. Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
Yang HW; Liu HY; Liu X; Zhang DM; Liu YC; Liu XD; Wang GJ; Xie L
Neurosci Lett; 2008 Apr; 434(3):299-303. PubMed ID: 18313849
[TBL] [Abstract][Full Text] [Related]
13. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.
Volk HA; Löscher W
Brain; 2005 Jun; 128(Pt 6):1358-68. PubMed ID: 15716304
[TBL] [Abstract][Full Text] [Related]
15. Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats.
Potschka H; Baltes S; Fedrowitz M; Löscher W
Neuropharmacology; 2011; 61(5-6):909-17. PubMed ID: 21736886
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
van Vliet EA; Redeker S; Aronica E; Edelbroek PM; Gorter JA
Epilepsia; 2005 Oct; 46(10):1569-80. PubMed ID: 16190927
[TBL] [Abstract][Full Text] [Related]
17. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Kwan P; Brodie MJ
Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
[TBL] [Abstract][Full Text] [Related]
18. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
19. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
van Vliet EA; Aronica E; Redeker S; Gorter JA
Epilepsia; 2004 Dec; 45(12):1506-16. PubMed ID: 15571508
[TBL] [Abstract][Full Text] [Related]
20. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.
Bartmann H; Fuest C; la Fougere C; Xiong G; Just T; Schlichtiger J; Winter P; Böning G; Wängler B; Pekcec A; Soerensen J; Bartenstein P; Cumming P; Potschka H
Epilepsia; 2010 Sep; 51(9):1780-90. PubMed ID: 20633036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
